Gelsemium Sempervirens in Anticipatory Anxiety

NCT00914329 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Anxiety

Interventions

DRUG: Gelsemium Sempervirens
DRUG: Gelsemium Sempervirens
DRUG: Placebo

Sponsor

University Hospital, Grenoble

Collaborators

[object Object]